section name header

Indications ⬇

REMS


Unlabeled Use:

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: Patch↑BP

Derm: application site burns, pain (after application of patch), transient burning

Neuro: ↓sensory function

Resp: cough

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

US Brand Names ⬆ ⬇

Capzasin-HP, Capzasin-P, DiabetAid Pain and Tingling Relief, Qutenza, Zostrix, Zostrix-HP

Action ⬆ ⬇

  • TopicalMay deplete and prevent the reaccumulation of a chemical (substance P) responsible for transmitting painful impulses from peripheral sites to the CNS.
  • TransdermalInitially stimulates the transient receptor potential vanilloid 1 (TRPV1) receptors on nociceptive nerve fibers in the skin; this is followed by pain relief thought to be due to a reduction in TRPV1-expressing nociceptive nerve endings.
Therapeutic effects:
  • Relief of discomfort associated with painful peripheral syndromes.

Classifications ⬆ ⬇

Therapeutic Classification: nonopioid analgesics (topical)

Pharmacokinetics ⬆ ⬇

Absorption: Unknown.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
topical1–2 wk2–4 wk‡unknown
transdermalunknownunknownunknown

‡May take up to 6 wk for head and neck neuralgias.



Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆

kap-SAY-sin